Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Management of endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: single arm, prospective multicenter study: Korean gynecologic oncology group study (KGOG2006).

Lee TS, Seong SJ, Kim JW, Ryu HS, Song ES, Nam BH.

Jpn J Clin Oncol. 2011 Jun;41(6):817-9. doi: 10.1093/jjco/hyr048. Epub 2011 Apr 7.

PMID:
21478178
2.

Comparison of diagnostic accuracy between endometrial curettage and pipelle aspiration biopsy in patients treated with progestin for endometrial hyperplasia: a Korean Gynecologic Oncology Group Study (KGOG 2019).

Kim MK, Seong SJ, Lee TS, Ki KD, Lim MC, Kim YH, Kim K, Joo WD.

Jpn J Clin Oncol. 2015 Oct;45(10):980-2. doi: 10.1093/jjco/hyv106. Epub 2015 Jul 22.

PMID:
26206899
3.

Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.

Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB.

Int J Gynecol Cancer. 2016 May;26(4):711-5. doi: 10.1097/IGC.0000000000000669.

PMID:
26905333
4.
5.

Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system.

Kresowik J, Ryan GL, Van Voorhis BJ.

Obstet Gynecol. 2008 Feb;111(2 Pt 2):547-9. doi: 10.1097/01.AOG.0000300716.84819.c6.

PMID:
18239018
6.

Prediction of regression and relapse of endometrial hyperplasia with conservative therapy.

Gallos ID, Ganesan R, Gupta JK.

Obstet Gynecol. 2013 Jun;121(6):1165-71. doi: 10.1097/AOG.0b013e31828cb563.

PMID:
23812448
7.

Efficacy of levonorgestrel-releasing intrauterine system versus oral progestins in treatment of simple endometrial hyperplasia without atypia.

Ismail MT, Fahmy DM, Elshmaa NS.

Reprod Sci. 2013 Jan;20(1):45-50. doi: 10.1177/1933719112459243.

PMID:
23203322
8.

Levonorgestrel-releasing intrauterine system vs oral progestins for non-atypical endometrial hyperplasia: a systematic review and metaanalysis of randomized trials.

Abu Hashim H, Ghayaty E, El Rakhawy M.

Am J Obstet Gynecol. 2015 Oct;213(4):469-78. doi: 10.1016/j.ajog.2015.03.037. Epub 2015 Mar 19. Review.

PMID:
25797236
9.

Oral Progestogens Versus Levonorgestrel-Releasing Intrauterine System for Treatment of Endometrial Intraepithelial Neoplasia.

Marnach ML, Butler KA, Henry MR, Hutz CE, Langstraat CL, Lohse CM, Casey PM.

J Womens Health (Larchmt). 2017 Apr;26(4):368-373. doi: 10.1089/jwh.2016.5774. Epub 2016 Nov 30.

PMID:
27901412
10.

The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia--a long-term follow-up study.

Varma R, Soneja H, Bhatia K, Ganesan R, Rollason T, Clark TJ, Gupta JK.

Eur J Obstet Gynecol Reprod Biol. 2008 Aug;139(2):169-75. doi: 10.1016/j.ejogrb.2008.02.022. Epub 2008 Apr 28.

PMID:
18440693
11.
12.

Levonorgestrel-releasing intrauterine device versus dydrogesterone for management of endometrial hyperplasia without atypia.

El Behery MM, Saleh HS, Ibrahiem MA, Kamal EM, Kassem GA, Mohamed Mel S.

Reprod Sci. 2015 Mar;22(3):329-34. doi: 10.1177/1933719114542014. Epub 2014 Jul 6.

PMID:
25001020
13.

Efficacy of the Levonorgestrel-Releasing Intrauterine System on IVF-ET Outcomes in PCOS With Simple Endometrial Hyperplasia.

Bian J, Shao H, Liu H, Li H, Fang L, Xing C, Wang L, Tao M.

Reprod Sci. 2015 Jun;22(6):758-66. doi: 10.1177/1933719114561553. Epub 2014 Dec 23.

PMID:
25536958
14.

Management of Endometrial Hyperplasia: A Survey of Members of the Korean Gynecologic Oncology Group.

Kim MK, Seong SJ, Kim JW, Bae DS, Jeon S, Kwon SH, Lee TS.

Int J Gynecol Cancer. 2015 Sep;25(7):1277-84. doi: 10.1097/IGC.0000000000000483.

PMID:
26067858
15.

Use of levonorgestrel-releasing intrauterine system in the prevention and treatment of endometrial hyperplasia.

Ewies AA, Alfhaily F.

Obstet Gynecol Surv. 2012 Nov;67(11):726-33. doi: 10.1097/OGX.0b013e318273570b. Review.

PMID:
23151756
16.

The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review.

Buttini MJ, Jordan SJ, Webb PM.

Aust N Z J Obstet Gynaecol. 2009 Jun;49(3):316-22. doi: 10.1111/j.1479-828X.2009.00981.x. Review.

PMID:
19566568
17.

Levonorgestrel-releasing intrauterine system (LNG-IUS) as an effective treatment option for endometrial hyperplasia: a 15-year follow-up study.

Scarselli G, Bargelli G, Taddei GL, Marchionni M, Peruzzi E, Pieralli A, Mattei A, Buccoliero AM, Fambrini M.

Fertil Steril. 2011 Jan;95(1):420-2. doi: 10.1016/j.fertnstert.2010.07.1044. Epub 2010 Aug 19.

PMID:
20723889
18.

Levonorgestrel-Releasing Intrauterine System vs. Oral Progestins for Treatment of Endometrial Hyperplasia.

Liegl S.

Am Fam Physician. 2016 Jun 1;93(11):948-9. No abstract available.

19.
20.

Supplemental Content

Support Center